NASDAQ:TLRY

Tilray Stock Forecast, Price & News

$17.37
+0.46 (+2.72 %)
(As of 06/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$16.32
$17.50
50-Day Range
$13.68
$21.43
52-Week Range
$4.41
$67.00
Volume21.50 million shs
Average Volume34.25 million shs
Market Capitalization$7.77 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.65
30 days | 90 days | 365 days | Advanced Chart
Receive TLRY News and Ratings via Email

Sign-up to receive the latest news and ratings for Tilray and its competitors with MarketBeat's FREE daily newsletter.


Tilray logo

About Tilray

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Nanaimo, Canada.

Headlines

Tilray Spikes With New Analyst Sentiment
Tilray Spikes With New Analyst Sentiment
June 3, 2021 |  pricetargets.com
Is It Too Late to Buy Tilray Stock?
Is It Too Late to Buy Tilray Stock?
June 17, 2021 |  finance.yahoo.com
4 Reddit Stocks With Double-Digit Earnings Growth
4 Reddit Stocks With Double-Digit Earnings Growth
June 16, 2021 |  finance.yahoo.com
3 Top Pot Stocks to Watch in June
3 Top Pot Stocks to Watch in June
June 16, 2021 |  finance.yahoo.com
Avoid These 3 Overvalued Reddit Stocks
Avoid These 3 Overvalued Reddit Stocks
June 14, 2021 |  stocknews.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.22 out of 5 stars

Medical Sector

941st out of 2,105 stocks

Medicinals & Botanicals Industry

6th out of 32 stocks

Analyst Opinion: 3.2Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Tilray (NASDAQ:TLRY) Frequently Asked Questions

Is Tilray a buy right now?

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Tilray in the last year. There are currently 9 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Tilray stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TLRY, but not buy additional shares or sell existing shares.
View analyst ratings for Tilray
or view top-rated stocks.

What stocks does MarketBeat like better than Tilray?

Wall Street analysts have given Tilray a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Tilray wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Tilray?

Tilray saw a decline in short interest during the month of May. As of May 28th, there was short interest totaling 29,970,000 shares, a decline of 13.9% from the May 13th total of 34,810,000 shares. Based on an average daily trading volume, of 25,660,000 shares, the short-interest ratio is presently 1.2 days. Approximately 7.1% of the company's shares are short sold.
View Tilray's Short Interest
.

When is Tilray's next earnings date?

Tilray is scheduled to release its next quarterly earnings announcement on Monday, August 9th 2021.
View our earnings forecast for Tilray
.

How were Tilray's earnings last quarter?

Tilray Inc (NASDAQ:TLRY) issued its quarterly earnings results on Monday, May, 10th. The company reported ($0.19) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.10) by $0.09. The company earned $48.02 million during the quarter, compared to analysts' expectations of $61.86 million. Tilray had a negative trailing twelve-month return on equity of 136.31% and a negative net margin of 336.84%.
View Tilray's earnings history
.

How has Tilray's stock price been impacted by COVID-19?

Tilray's stock was trading at $7.09 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, TLRY shares have increased by 145.0% and is now trading at $17.37.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for TLRY?

14 Wall Street analysts have issued 12-month price targets for Tilray's stock. Their forecasts range from $4.75 to $32.00. On average, they anticipate Tilray's stock price to reach $20.28 in the next year. This suggests a possible upside of 16.7% from the stock's current price.
View analysts' price targets for Tilray
or view top-rated stocks among Wall Street analysts.

Who are Tilray's key executives?

Tilray's management team includes the following people:
  • Mr. Edward Wood Pastorius Jr., Chief Revenue Officer (Age 50)
  • Mr. Brendan Kennedy, Pres, CEO & Director (Age 46)
  • Mr. Mark Castaneda, CFO, Sec. & Treasurer (Age 53)
  • Dr. Catherine Jacobson, Director of Clinical Research & Member of Medical Advisory Board

What is Brendan Kennedy's approval rating as Tilray's CEO?

32 employees have rated Tilray CEO Brendan Kennedy on Glassdoor.com. Brendan Kennedy has an approval rating of 51% among Tilray's employees. This puts Brendan Kennedy in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Tilray's key competitors?

What other stocks do shareholders of Tilray own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tilray investors own include (CGC), Cronos Group (CRON), Aurora Cannabis (ACB), NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Tesla (TSLA), Micron Technology (MU), Netflix (NFLX) and Square (SQ).

When did Tilray IPO?

(TLRY) raised $135 million in an initial public offering on Thursday, July 19th 2018. The company issued 9,000,000 shares at $14.00-$16.00 per share. Cowen and Company served as the underwriter for the IPO and Roth Capital Partners and Northland Securities were co-managers.

What is Tilray's stock symbol?

Tilray trades on the NASDAQ under the ticker symbol "TLRY."

Who are Tilray's major shareholders?

Tilray's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Mirae Asset Global Investments Co. Ltd. (1.39%), Graham Capital Management L.P. (0.52%), TIG Advisors LLC (0.28%), Swiss National Bank (0.17%), Princeton Global Asset Management LLC (0.17%) and Freestone Capital Holdings LLC (0.12%). Company insiders that own Tilray stock include Brendan Kennedy, Carl A Merton, Christine StClare, Maryscott Greenwood and Michael Auerbach.
View institutional ownership trends for Tilray
.

Which major investors are selling Tilray stock?

TLRY stock was sold by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., JPMorgan Chase & Co., Cubist Systematic Strategies LLC, Bridges Investment Management Inc., Sigma Planning Corp, HBK Sorce Advisory LLC, Aua Capital Management LLC, and GSA Capital Partners LLP. Company insiders that have sold Tilray company stock in the last year include Brendan Kennedy, Carl A Merton, Christine StClare, Maryscott Greenwood, and Michael Auerbach.
View insider buying and selling activity for Tilray
or view top insider-selling stocks.

Which major investors are buying Tilray stock?

TLRY stock was purchased by a variety of institutional investors in the last quarter, including Graham Capital Management L.P., TIG Advisors LLC, Mirae Asset Global Investments Co. Ltd., Capital Fund Management S.A., Swiss National Bank, Axiom Investment Management LLC, Axiom Investment Management LLC, and Princeton Global Asset Management LLC.
View insider buying and selling activity for Tilray
or or view top insider-buying stocks.

How do I buy shares of Tilray?

Shares of TLRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tilray's stock price today?

One share of TLRY stock can currently be purchased for approximately $17.37.

How much money does Tilray make?

Tilray has a market capitalization of $7.77 billion and generates $210.48 million in revenue each year. The company earns $-271,070,000.00 in net income (profit) each year or ($0.83) on an earnings per share basis.

How many employees does Tilray have?

Tilray employs 1,030 workers across the globe.

What is Tilray's official website?

The official website for Tilray is www.tilray.com.

Where are Tilray's headquarters?

Tilray is headquartered at 1100 MAUGHAN ROAD, NANAIMO A1, V9X 1J2.

How can I contact Tilray?

Tilray's mailing address is 1100 MAUGHAN ROAD, NANAIMO A1, V9X 1J2. The company can be reached via phone at 206-432-9325.


This page was last updated on 6/22/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.